DHG Pharmaceutical JSC (HOSE: DHG)

Market Cap	13.99T
Revenue (ttm)	5.00T
Net Income (ttm)	813.84B
Shares Out	130.75M
EPS (ttm)	6,224.62
PE Ratio	17.19
Forward PE	13.92
Dividend	7,500.00 (7.01%)
Ex-Dividend Date	Aug 8, 2024

Volume	17,300
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	95,000 - 125,900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 18, 2024

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products primarily in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in health supplements and pharmaceuticals cosmeceuticals. It also exports its products to Moldova, Ukraine, Romania, Myanmar, Russi...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,789
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2023, DHG Pharmaceutical JSC's revenue was 5.02 trillion, an increase of 7.26% compared to the previous year's 4.68 trillion. Earnings were 1.02 trillion, an increase of 6.31%.